ACL Healius Bid Bordering on the Pathological
Even though the Covid testing boom is over, Australian Clinical Labs still wants to create the country’s largest pathology provider by taking over the number one tester, Healius.
Read More
Australian Clinical Labs Limited
ACL is a leading Australian private provider of pathology services. ACL is one of the largest private hospital pathology businesses nationally1 and in its four established regions of Western Australia, Victoria, South Australia and the Northern Territory, has an equivalent market position in community pathology2 to Sonic Healthcare and Healius. ACL has a growing presence in New South Wales and the Australian Capital Territory3 and has recently expanded into Queensland.
Videos
Videos coming soon for Australian Clinical Labs Limited.
News
ACL – Citi rates the stock as Neutral
The broker raises its target price to $5 from $4.50. A Neutral rating is retained, assuming a normalisation of growth to around 5%.
Read More
Aust Clinical Labs Passes First Post-Listing Trial
Pathology group Australian Clinical Labs has, like its bigger rival Sonic, enjoyed a very good Covid lockdown testing boom, with the recently-listed company already upgrading its prospectus forecasts.
Read More
